TTS 2022 - SYMPOSIA LISTING

Organised by

Dr. Franz Köhler Chemie GmbH

Sunday, September 11, 16:30-17:30

Symposium for Organ Protection - Paths to the Future

Click here for more details

Organised by

RMEI

supported by an independent educational grant from CSL Behring LLC

Sunday, September 11, 16:30-17:30

Chronic Active AMR in Renal Transplant: A Closer Look at Pathophysiology, Diagnosis, and Emerging Therapies

Click here for more details

Organised by

Vera Therapeutics

Sunday, September 11, 16:30-17:30

Looking to the Future: Update on International Guidelines for the Management of BK DNAemia and Nephropathy in Kidney Transplant Recipients and Potential New Therapies on the Horizon

Click here for more details

Organised by

Astra Zeneca

Sunday, September 11, 17:30-18:30

Innovative approaches for prevention and treatment of COVID-19 in high risk populations

Click here for more details

Organised by

Bridge to Life

Sunday, September 11, 17:30-18:30

You gotta have HOPE

Click here for more details

Organised by

Natera

Monday, September 12, 13:10-14:10

Revolutionizing Transplant Care: Optimizing dd-cfDNA and Molecular Diagnostics

Click here for more details

Expo studio session sponsored by

CareDx

Monday, September 12, 16:00-16:25

Donor Derived Cell-Free DNA (AlloSure and AlloSeq cfDNA) in Transplantation

Click here for more details

Organised by

Eurofins

Monday, September 12, 17:35-18:35

Combining Blood Gene Expression Biomarkers and dd-cfDNA

Click here for more details

Organised by

Astellas

Tuesday, September 13, 13:15-14:15

Improving Organ Transplant Outcomes: A Multidimensional Perspective

Click here for more details

Organised by

CareDx

Wednesday, September 14, 13:15-14:15

Evolving the Clinical Utility of dd-cfDNA (AlloSure/AlloSeq cfDNA) in Organ Transplantation

Click here for more details

Expo studio session sponsored by

TAKEDA

Wednesday, September 14, 11:40 a.m.-12 p.m.

How Do You Identify and Manage Refractory CMV In Solid Organ Transplant Recipients? An Interactive Case-Based Discussion.

Click here for more details